Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports
Pfizer withdrew an application last month seeking EUA for its product in India after the DCGI declined its request to skip a small…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDSCO
The Brexit effect
Brexit is finally a reality and though India Pharma Inc expects some glitches in the short-term, it is optimistic about its impact…
Pfizer drops India vaccine application after regulator seeks local trial
Pfizer said on Friday that it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after…
CDSCO’s expert panel recommends approval for phase 1 trial of Bharat Biotech’s nasal vaccine for…
An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes
Centaur Pharma to start post-marketing surveillance study of diabetic drug by end of January 2021
The company, with permission to conduct the PMS study in 200 to 500 patients with diabetic foot ulcers, plans to enrol them from…
Drug activist group AIDAN raises concerns over EUA for COVAXIN
Urging the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN, it has aked the drug…
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D
The company will now be initiating Phase III clinical trial in around 30,000 volunteers
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
SEC recommends EUA for Covaxin from Bharat Biotech
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…
SEC recommends EUA for Covishield, DCGI nod awaited
The SEC is also looking at the EUA applications of Pfizer and Bharat Biotech